GlassScriptPhysician profile
Shady Henien
NPI 1760820930
$105,246.77
in general payments reported to CMS, 2019-2025
32 companies · $845 in 2025
The $845 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45K · 2021: $23K · 2022: $29K · 2023: $4,495 · 2024: $3,088 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,644 · Travel and Lodging: $2,065 · Consulting Fee: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,643.79 |
| Travel and Lodging | $2,064.82 |
| Consulting Fee | $718.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $45,000.02 | 2020-2022 | |
| Becton, Dickinson and Company | $23,218.75 | 2021-2024 | |
| Medtronic Vascular, INC. | $21,267.15 | 2020 | |
| Penumbra, INC. | $4,525.89 | 2022-2024 | Indigo System |
| Medtronic, INC. | $2,459.94 | 2021-2025 | Corevalve Evolut R |
| W. L. Gore & Associates, INC. | $1,649.11 | 2021-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Edwards Lifesciences Corporation | $1,458.23 | 2020-2024 | Pascal |
| Abbott Laboratories | $952.43 | 2021-2025 | Mitraclip, Navitor, Jot Dx |
| Inari Medical, INC. | $877.34 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $572.24 | 2022-2024 | Watchman Flx, Watchman Access System, Watchman |
| Abiomed | $407.31 | 2021-2023 | Impella |
| Pfizer INC. | $356.30 | 2022-2025 | |
| Ge Healthcare | $340.00 | 2022 | |
| Cardiovascular Systems INC. | $306.46 | 2022 | |
| Novartis Pharmaceuticals Corporation | $291.54 | 2022-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $220.75 | 2023-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $202.69 | 2022-2025 | Verquvo, Capvaxive |
| Amgen INC. | $162.67 | 2022-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $161.84 | 2023-2025 | Lifevest |
| Shockwave Medical, INC | $135.95 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $118.55 | 2022-2024 | Xarelto |
| United Therapeutics Corporation | $100.00 | 2020 | |
| Kestra Medical Technology Services, INC. | $83.95 | 2024-2025 | Assure Wcd |
| Philips North America LLC | $83.68 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Zoll Circulation INC | $68.45 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Astrazeneca Pharmaceuticals LP | $67.17 | 2022-2024 | Farxiga |
| Cardiva Medical, INC. | $42.71 | 2025 | Savvywire |
| Impulse Dynamics (USA) INC. | $29.37 | 2023 | Optimizer |
| Cvrx, INC. | $22.75 | 2024 | Barostim Neo System |
| Stryker Corporation | $22.24 | 2025 | Clottriever Bold Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $21.15 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $20.14 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shady Henien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.